Insulet Corp Enters Material Agreement, Takes on New Financial Obligation

TL;DR

**Insulet just took on a new financial obligation and entered a material agreement, details pending.**

AI Summary

Insulet Corporation, a medical device company, filed an 8-K on January 25, 2024, reporting an "Entry into a Material Definitive Agreement" and the "Creation of a Direct Financial Obligation" on January 24, 2024. This indicates the company has entered into a significant new contract or taken on new debt, which could impact its financial health and future operations. Investors should pay close attention to the details of this agreement, as it could affect Insulet's profitability and growth prospects.

Why It Matters

This filing signals a potentially significant change in Insulet's financial structure or operational commitments, which could impact its future earnings and stock valuation. Understanding the nature of this agreement is crucial for assessing the company's risk and growth potential.

Risk Assessment

Risk Level: medium — The filing indicates a new financial obligation and material agreement without providing specific details, creating uncertainty about its potential positive or negative impact.

Analyst Insight

A smart investor would await further details on the "Material Definitive Agreement" and "Direct Financial Obligation" to understand their nature, size, and potential impact on Insulet's balance sheet and future profitability before making any investment decisions.

Key Players & Entities

• INSULET CORP (company) — the registrant filing the 8-K
• January 24, 2024 (date) — date of the earliest event reported
• January 25, 2024 (date) — date the 8-K was filed
• 001-33462 (dollar_amount) — Commission File Number
• 100 Nagog Park, Acton, MA 01720 (company) — business address of Insulet Corporation
• 978-600-7000 (dollar_amount) — registrant's telephone number

FAQ

Key Financial Figures

• $0.001 — ange on which registered Common Stock, $0.001 Par Value Per Share PODD The NASDAQ
• $487,500,000.00 — Agent. Pursuant to the Amendment, the $487,500,000.00 in aggregate principal amount of term l

Filing Documents

• d730170d8k.htm (8-K) — 28KB
• d730170dex101.htm (EX-10.1) — 1324KB
• 0001193125-24-014842.txt ( ) — 1804KB
• podd-20240124.xsd (EX-101.SCH) — 3KB
• podd-20240124_lab.xml (EX-101.LAB) — 17KB
• podd-20240124_pre.xml (EX-101.PRE) — 11KB
• d730170d8k_htm.xml (XML) — 3KB

01

Item 1.01 Entry into a Material Definitive Agreement. On January 24, 2024, Insulet Corporation (the " Company ") entered into the Fifth Amendment to Credit Agreement (the " Amendment ") with the lenders and other parties thereto and Morgan Stanley Senior Funding, Inc., as administrative agent (the " Agent "), amending that certain Credit Agreement, dated as of May 4, 2021 (as previously amended, supplemented or modified, the " Credit Agreement ", and as amended by the Amendment, the " Amended Credit Agreement "), by and among the Company, the lenders and other parties thereto and the Agent. Pursuant to the Amendment, the $487,500,000.00 in aggregate principal amount of term loans outstanding under the Credit Agreement (the " Existing Term Loans ") were replaced with an equal amount of new term loans (the " New Term Loans ") having substantially similar terms as the Existing Term Loans, except with respect to the interest rate applicable to the New Term Loans and certain other provisions. Proceeds from the New Term Loans, together with cash on hand, were used to refinance the Existing Term Loans and pay accrued and unpaid interest thereon. In addition, the Company and its revolving facility lenders amended the Credit Agreement to reduce the interest rate margin applicable to revolving loans outstanding thereunder. The interest rate margin applicable to the New Term Loans was reduced from 2.25% to 2.00%, in the case of base rate loans, and from 3.25% to 3.00%, in the case of term SOFR loans, with a SOFR floor of 0.00% (reduced from 0.50%). The range of interest rate margins applicable to the revolving facility loans was reduced from 2.75% to 3.25% to 2.00% to 3.00% for term SOFR loans, with the interest rate margin applicable from time to time dependent upon the Company's adjusted total leverage ratio (as defined in the Amended Credit Agreement). The SOFR floor applicable to revolving facility loans remains unchanged at 0.00%. The credit spread adjustment was e

03

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth under Item 1.01 above is incorporated by reference into this Item 2.03.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. The following exhibit is filed as part of this report: No. Exhibit 10.1 Fifth Amendment to Credit Agreement, dated January 24, 2024, among Insulet Corporation, Insulet MA Securities Corporation, Morgan Stanley Senior Funding, Inc., as administrative agent, and the other lenders party thereto. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned thereunto duly authorized. INSULET CORPORATION Date: January 25, 2024 By: /s/ Lauren Budden Lauren Budden Interim Chief Financial Officer and Treasurer, Group Vice President, Chief Accounting Office and Controller [Signature Page to 8-K]

View Full Filing

View this 8-K filing on SEC EDGAR